20:37 , Jun 7, 2019 |  BC Extra  |  Company News

June 7 Company Quick Takes: Expanded label for PTC’s DMD drug; plus Achaogen, ICER on migraine and Nucala

PTC’s DMD drug approved in patients ages 2-5  FDA approved an sNDA for Emflaza deflazacort from PTC Therapeutics Inc. (NASDAQ:PTCT) to treat Duchenne muscular dystrophy in patients ages 2-5. The drug was first approved in...
19:43 , Apr 10, 2019 |  BC Extra  |  Clinical News

Aetion, Brigham and Women's partnerships will inform FDA RWE standards

FDA is expanding its real-world evidence partnership with Brigham and Women's Hospital and Aetion to use real-world evidence to predict clinical outcomes from trials. The results from this expansion should help the agency identify when...
05:01 , Feb 5, 2019 |  BC Extra  |  Financial News

Real-world analytics company Aetion tops off series B

Aetion Inc. (New York, N.Y.) raised an additional $27 million in its series B round Tuesday to continue building its real-world evidence analytics platform. New investors Sanofi (Euronext:SAN; NASDAQ:SNY), UCB S.A. (Euronext:UCB), McKesson Ventures and...
17:21 , May 11, 2018 |  BC Week In Review  |  Company News

Aetion partners with Brigham and FDA to replicate clinical trials with real-world evidence

Analytics software company Aetion Inc. (New York, N.Y.) partnered with FDA and Brigham and Women’s Hospital to recreate 30 published clinical trials using real-world evidence (RWE) in order to determine if the data can be...
19:14 , May 8, 2018 |  BC Extra  |  Company News

Aetion partnership to replicate clinical trials with real-world evidence

Analytics software company Aetion Inc. (New York, N.Y.) partnered with FDA and Brigham and Women’s Hospital to recreate 30 published clinical trials using real-world evidence (RWE) in order to determine if the data can be...
13:43 , Apr 13, 2018 |  BC Week In Review  |  Financial News

Aetion raises $36.4M in series B led by NEA

Healthcare analytics company Aetion Inc. (New York, N.Y.) raised $36.4 million in a series B round led by NEA with participation from new investor Amgen Ventures and existing investors Flare Capital Partners, Lakestar and Oxeon...
18:52 , Apr 11, 2018 |  BC Extra  |  Financial News

NEA leads Aetion's $36.4M series B

Healthcare analytics company Aetion Inc. (New York, N.Y.) raised $36.4 million in a series B round led by NEA with participation from new investor Amgen Ventures and existing investors Flare Capital Partners, Lakestar and Oxeon...